{"id":822554,"date":"2025-03-06T08:54:05","date_gmt":"2025-03-06T13:54:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/"},"modified":"2025-03-06T08:54:05","modified_gmt":"2025-03-06T13:54:05","slug":"achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/","title":{"rendered":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE and VANCOUVER, British Columbia, March  06, 2025  (GLOBE NEWSWIRE) &#8212; Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tuesday, March 11, 2025, at 8:30 AM EDT.<\/p>\n<p>To access the webcast, please use the following link <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S72Gq59-m8-RE3_vdyvE-2Vhci6RmTL3HPr0rzE-Y82RIIAhMEvJr7__7PRgUubTj_WDS5BHfGPVxe4O6qjW1aIpxs01Wy1LG76ADMzNX8va4RkBudQAys5rRcWjIcDBeQ-vZq5m7xC6r9A50uyseA==\" rel=\"nofollow\" target=\"_blank\"><u>4Q24 Webcast<\/u><\/a>. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. &amp; Canada) or 1 201-689-7817 (International) and referencing conference ID 13751745. A webcast replay will be available approximately three hours after the call and will be archived on the website for 90 days.<\/p>\n<p>\n        <strong>About Achieve Life Sciences, Inc.<\/strong>\u00a0<br \/>Achieve Life Sciences is a late-stage specialty pharmaceutical company committed to addressing the global smoking health and nicotine dependence epidemic through the development and commercialization of cytisinicline. The company has successfully completed two Phase 3 studies with cytisinicline for smoking cessation and one Phase 2 study with cytisinicline in vaping cessation. The company has fully enrolled its ongoing open-label safety study with cytisinicline and plans to submit its new drug application for smoking cessation in Q2 2025. Achieve has also conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication.<\/p>\n<p>\n        <strong>About Cytisinicline<\/strong><br \/>\n        <br \/>There are approximately 29 million adults who smoke combustible cigarettes.<sup>1<\/sup>\u00a0Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide and nearly half a million deaths in the United States annually.<sup>2,3<\/sup>\u00a0More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke.<sup>3<\/sup><\/p>\n<p>In addition, there are over 11 million adults in the United States who use e-cigarettes, also known as vaping.<sup>4<\/sup>\u00a0In 2024, approximately 1.6 million middle and high school students in the United States reported using e-cigarettes.<sup>5<\/sup>\u00a0There are no FDA-approved treatments indicated specifically as an aid to nicotine e-cigarette cessation. Cytisinicline has been granted Breakthrough Therapy designation to address this critical need.<\/p>\n<p>Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in treating nicotine addiction for smoking and e-cigarette cessation by interacting with nicotine receptors in the brain, reducing the severity of nicotine craving symptoms, and reducing the reward and satisfaction associated with nicotine products. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine addiction and has not been approved by the Food and Drug Administration for any indication in the United States.<\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and nature of cytisinicline clinical development and regulatory review and approval, data results and commercialization activities, the potential market size for cytisinicline, the potential benefits, efficacy, safety and tolerability of cytisinicline, the development and effectiveness of new treatments, and the successful commercialization of cytisinicline. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management\u2019s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that cytisinicline may not demonstrate the hypothesized or expected benefits; the risk that Achieve may not be able to obtain additional financing to fund the development and commercialization of cytisinicline; the risk that cytisinicline will not receive regulatory approval or be successfully commercialized; the risk that new developments in the smoking and vaping cessation landscapes require changes in business strategy or clinical development plans; the risk that Achieve\u2019s intellectual property may not be adequately protected; general business and economic conditions; risks related to the impact on our business of macroeconomic and geopolitical conditions, including inflation, volatile interest rates, volatility in the debt and equity markets, actual or perceived instability in the global banking system, global health crises and pandemics and geopolitical conflict and the other factors described in the risk factors set forth in Achieve\u2019s filings with the Securities and Exchange Commission from time to time, including Achieve\u2019s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable.<\/p>\n<p>\n        <strong>Achieve Contact<\/strong><br \/>\n        <br \/>Nicole Jones<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MPfvxx4uICRoq7Nf0x-JCT8dAYte47AqAKRQeqwwpiOj_TbRI9BTxliCp7EK12JX7pAUvflhtLZ6HV3aj158wzgRR3ccq_9SvY8gLfqA1pyGGxs9Af1pyXAqitxZdAr4UyFcsWTwo9zoPiLbdOByDWMjEKBRdYrAOo-B7nwDDuoK96tgbdXhYmIG_KwI5pHlInrPhBczN2SAfQvKMLW5wzmOailbZP4DFq_xDqGUYsTPjqK1p6XT2nn7qrBkWat-wGocaoe8PEuKzPDm7c1eUDMk4gtH6M2hpb-fgn6-2mHrYcCmLMlV3fq7-yM0ieCzmRyNrUF3Ad3Pm7bnET7Lq34XXBD-r174Bmybc1K5SWUgylm2685v3R3VtLKL9UruK-pEAIIpHKNg_8uoTqD25UyXG6iWKDBmyA-l17xsBAoLk2C5W1qBsnoDUwrFuGiLiiuouhkvutxlWOTpDVPyPHtViWTaP7yHHG3jAoOVRTEFXG1eqdCIKgp5RLlm-MWRaT4499OVF9rHyAhYEtFzHA==\" rel=\"nofollow\" target=\"_blank\"><u>ir@achievelifesciences.com<\/u><\/a><br \/>425-686-1510<\/p>\n<p>\n        <strong>References<\/strong><br \/>\n        <br \/>\n        <sup>1<\/sup>VanFrank B, Malarcher A, Cornelius ME, Schecter A, Jamal A, Tynan M. Adult Smoking Cessation \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep 2024;73:633\u2013641.<br \/><sup>2<\/sup>World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World Health Organization, 2017.<br \/><sup>3<\/sup>U.S. Department of Health and Human Services. The Health Consequences of Smoking \u2013 50 Years of Progress. A Report of the Surgeon General, 2014.<br \/><sup>4<\/sup>Cornelius ME, Loretan CG, Jamal A, et al. Tobacco Product Use Among Adults \u2013 United States, 2021. MMWR Morb Mortal Wkly Rep 2023;72:475\u2013483.<br \/><sup>5<\/sup>Jamal A, Park-Lee E, Birdsey J, et al. Tobacco Product Use Among Middle and High School Students \u2014 National Youth Tobacco Survey, United States, 2024. MMWR Morb Mortal Wkly Rep 2024;73:917\u2013924.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGE5ZTBhYzAtNjExMS00MjY3LWE2MjUtMTI0YmEyZmRkNjBkLTUwMDA4NTY1NA==\/tiny\/Achieve-Life-Sciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) &#8212; Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tuesday, March 11, 2025, at 8:30 AM EDT. To access the webcast, please use the following link 4Q24 Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. &amp; Canada) or 1 201-689-7817 (International) and referencing conference ID 13751745. A webcast replay will be available approximately three hours after the call and will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-822554","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) &#8212; Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tuesday, March 11, 2025, at 8:30 AM EDT. To access the webcast, please use the following link 4Q24 Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. &amp; Canada) or 1 201-689-7817 (International) and referencing conference ID 13751745. A webcast replay will be available approximately three hours after the call and will be &hellip; Continue reading &quot;Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-06T13:54:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025\",\"datePublished\":\"2025-03-06T13:54:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/\"},\"wordCount\":929,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/\",\"name\":\"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==\",\"datePublished\":\"2025-03-06T13:54:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/","og_locale":"en_US","og_type":"article","og_title":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - Market Newsdesk","og_description":"SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) &#8212; Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tuesday, March 11, 2025, at 8:30 AM EDT. To access the webcast, please use the following link 4Q24 Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. &amp; Canada) or 1 201-689-7817 (International) and referencing conference ID 13751745. A webcast replay will be available approximately three hours after the call and will be &hellip; Continue reading \"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-06T13:54:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025","datePublished":"2025-03-06T13:54:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/"},"wordCount":929,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/","name":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==","datePublished":"2025-03-06T13:54:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTczMiM2NzkyNzcyIzUwMDA4NTY1NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/822554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=822554"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/822554\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=822554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=822554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=822554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}